Role of NF-κB as a Prognostic Marker in Breast Cancer: A Pilot Study in Indian Patients

Indian Journal of Surgical Oncology

Volumn 4, Issue 3, 2013, Pages 242-247

  Sarkar, D K ^a,d   Jana, Debarshi ^a,d   Patil, P S ^a,e   Chaudhari, K S ^a,c   Chattopadhyay, B K ^a   Chikkala, B R ^a,e   Mandal, S ^b   Chowdhary, P ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^c not available   (India)

^d not available   (India)

^e Doctor's Hostel   (India)

Author keywords

Breast cancer; Immunohistochemistry (IHC); NF B p65 overexpression; Nottingham Prognostic Index (NPI); Nuclear factor B (NF B); Prognostic marker

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER TISSUE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIAN; LYMPH NODE; MAJOR CLINICAL STUDY; NOTTINGHAM PROGNOSTIC INDEX; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERTIARY HEALTH CARE; WESTERN BLOTTING;

EID: 84884143475     PISSN: 09757651     EISSN: 09766952     Source Type: Journal    
DOI: 10.1007/s13193-013-0234-y     Document Type: Article

References (19)

1. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
2. Radhakrishnan SK, Kamalakaran S (2006) Pro-apoptotic role of NF-κB: implications for cancer therapy. Biochim Biophys Acta 1766: 53-62.
3. Greten FR, Karin M (2004) The IKK/NF-kB activation pathway-a target for prevention. Cancer Lett 206: 193-199.
4. van Laere SJ, van der Auwera I, van den Eynden GG, van Dam P, van Marck EA, Vermeulen PB, Dirix LY (2007) NF-kB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. Br J Cancer 97: 659-669.
5. Shostak K, Chariot A (2011) Breast Cancer Res 13: 214.
6. Ali S, Coombes C (2002) Nat Rev Mol Cell Biol 2: 101-115.
7. Kalkhoven E, Wissink S, van der Saag PT, van der Burg B (1996) J Biol Chem 271: 6217-6224.
8. Merkhofer EC, Cogswell P, Baldwin AS (2010) Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα. Oncogene 29: 1238-1248.
9. Sethi G, Sung B, Aggarwal BB (2008) Nuclear factor-κB activation: from bench to bedside. Exp Biol Med 233: 21-31.
10. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC (2005) The NF-κB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12: S37-S46.
11. Zhoua Y, Eppenberger-Castorib S, Marxa C, Yaua C, Scotta GK, Eppenbergerb U, Benz CC (2005) Activation of nuclear factor-κB (NF-κB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 37: 1130-1144.
12. Biswas DK, Cruz AP, Gansberger E, Pardee AB (2000) Epidermal growth factor-induced nuclear factor kB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. PNAS 97(15): 8542-8547.
13. Nakshatri H, Bhat-Nakshatri P, Martin DA, Gouet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17(7): 3629-3639.
14. Hou M-F, Lin S-B, Yuan S-SF, Tsai S-M, Wu S-H, Ou-Yang F, Hsieh J-S, Tsai K-B, Huang T-J, Tsai L-Y (2003) The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin Chim Acta 334: 137-144.
15. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255): 539-545.
16. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
17. Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, Pardee AB (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63: 290-295.
18. Biswas DK, Dai S-C, Cruz A, Weiser B, Graner E, Pardee AB (2001) The nuclear factor kappa B (NF-kB): a potential therapeutic target for estrogen receptor negative breast cancers. PNAS 98: 10386-10391.
19. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NFkappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639.